Posts filed under: conference

ta-Scan SCOPE Europe 2018 Barcelona

Events Published on September 17, 2018

SCOPE Europe 2018: Join us at the First European Edition

Join us in October at the inaugural edition of SCOPE Europe in Barcelona, Spain. Visit the ta-Scan team at booth #6 or make an appointment with our attendees:

Chairperson’s Remarks

David Cocker, Chief Scientific Officer, ta-Scan Business Intelligence Systems, MDCPartners

DAY 1, Tuesday 16 October, 13:55h
David Cocker, Chief Scientific Officer, ta-Scan Business Intelligence Systems, MDCPartners / Anju Software
Track 1: Analytics-Driven Feasibility, Site Selection and Study Activation

 

About SCOPE Europe

Building on the success of its long-running US-based counterpart, Summit for Clinical Trials Operations Executives Europe (SCOPE Europe) is a two-day event serving clinical operations executives, functional heads, category managers and those responsible for the planning and management of clinical trials in Europe and the rest of the world. The event will feature opening and closing plenary keynote sessions, three conference tracks, interactive breakout discussion groups and networking. It is an opportunity for leaders from large, mid-sized, and small pharma, specialty pharma, biotech, vendor companies, and academic research centers to come together to share best practices and discuss the new era of analytics-driven and patient-centric trials. Topics to be discussed include protocol development, global site selection, feasibility, site management, patient engagement, enrollment planning, patient recruitment, patient retention, improving site-study activation and performance, functional/full-service outsourcing and partnerships, new regulations and guideline, Risk-Based Monitoring (RBM), and improving overall quality and speed of clinical trials.

Register to join us

Have a look at the agendahttp://www.scopesummiteurope.com/2018-brochure-download-form

Register here to join us in Barcelona: https://chidb.com/reg/scoe/reg.asp

We hope to see you there!

SCOPE 2018 ta-Scan David Cocker

Events Published on December 18, 2017

Catch up with ta-Scan during SCOPE 2018 at booth 300

On February 12-15, 2018 the ta-Scan team has its annual appointment with SCOPE 2018. Meet us in the Hyatt Regency in Orlando, Florida at booth 300 to discover what we have been working on the last year!

Find Medical Experts on the go with ta-Scan Podium

Next to a completely updated and optimized user interface, ta-Scan also has a new tool in store. Our mobile application ta-Scan Podium helps Clinical Ops, Medical Affairs teams, and Medical Science Liaisons to identify the right Medical Experts. Have a look at how Podium works.

ta-Scan Podium Mobile Semantic Search Expert Profiling

Meeting up

If you want to get an exclusive preview of Podium and learn more about our other (custom) software solutions, visit us on SCOPE 2018 at booth #300 or make an appointment with the ta-Scan team:

Summit for Clinical Operations Executives

The 9th Annual SCOPE Summit, taking place February 12-15, 2018 in Orlando, FL, will offer four stimulating days of in-depth discussions in 18 different conferences, 3 plenary keynote sessions, and the ever-popular interactive breakout discussions focused on advances and innovative solutions in all aspects of clinical trial planning, management and operations: Site Selection and Management, Patient Engagement, Recruitment and Retention, Protocol Optimization, Feasibility, Data Strategy & Analytics, Sensors and Wearables, Project Management, Outsourcing, Forecasting, Resource Management and Capacity Planning, Budgeting and Contracting, Quality (QbD) in Trial Conduct, Risk-Based Monitoring, Artificial Intelligence (AI), Post-Marketing Studies, Observational Research, Clinical Supply Chain, and Precision Medicine. View SCOPE’s programs here.

ta-Scan and MDCPartners at Immuno-Oncology Summit 2017 Boston

Events Published on June 11, 2017

Connect with MDCPartners at the Immuno-Oncology Summit 2017

Connect with MDCPartners at Immuno-Oncology Summit 2017 from August 28 to September 1, 2017 in Boston, MA. Visit MDCPartners at booth #32 to discover next generation targeted immunotherapies and find new ways to navigate clinical data and overlap internal data with MDCPartners’ public data cloud.

Join us in Boston

Would you like to know how our clinical business intelligence software ta-Scan or our other data solutions can help with your company’s data challenges? Then feel free to pop by booth #32 or make an appointment with MDCPartners’ Director of Business Development, North America Matt Tumasz and/or Strategic Analyst, Oncology, Dr. Jonathan Crowther. They will gladly show you our state of the art tools.

Register Today

Secure your place now if you want to connect with the ta-Scan team in Boston. MDCPartners has arranged for an exclusive discount on CHI’s Immuno-Oncology Summit. Use promo code MDC when registering to receive your $200 registration discount. This discount applies to conference programs only and cannot be used on short courses, combined with other offers, or transferred.

How to register:
Online: https://chidb.com/reg/imx/reg.asp
By Phone: +1 781-972-5472

Immuno-Oncology Summit 2017 Program

Now in its fifth year, the Immuno-Oncology Summit will return to Boston again this August 28-September 1 with the goal of supporting researchers in developing the next generation of immunotherapies. Immuno-oncology researchers are changing the way we treat cancer by unleashing the immune system and achieving functional cures in some cancers.

This year’s IO Summit has been designed to give attendees a complete picture of the field and its advances with 12 conference tracks, 1 in-depth training seminar, and 4 instructional short courses. Topics include immunotherapy discovery, development, biomarkers, and translational oncology as well as emerging topic areas such as cancer vaccines, oncolytic viruses, and advances in synthetic biology techniques. Overall, this event provides a focused look at how researchers are applying new science and technology in the development of effective and safe immunotherapies.

Download the digital brochure for full details.

We look forward to seeing you in Boston!

DIA 2017 ta-Scan mobile app David Cocker

Events Published on June 9, 2017

Meet David Cocker at DIA 2017 and discover the new ta-Scan mobile app!

MDCPartners‘ CSO David Cocker will be attending the DIA 2017 meeting in Chicago on June 18-22 to showcase ta-Scan‘s new mobile app.

About DIA 2017

The Drug Information Association, a non-profit association, is the only global organization dedicated to bringing health care product development professionals together in a trusted, global, neutral environment to share insights and drive action in health care product development and life cycle management.

ta-Scan Mobile App

ta-Scan now has its own mobile app! Have a look at the video below: it’s a little demo on how it works. This tool enables MSLs to search for high ranking investigators on the go. Clinical business intelligence is now truly at your fingertips.

Meet us in Chicago

Book an appointment now to connect with David Cocker in Chicago.

We look forward to seeing you in Chicago!

ta-Scan and MDCPartners at Clinical Trial Innovation Summit Boston 2017

Events Published on March 15, 2017

Join MDCPartners at Clinical Trial Innovation Summit 2017

CHI’s 6th Annual Clinical Trial Innovation Summit brings together more than 250 leaders from across pharma, biotech and academia to share case studies and best practices on effective clinical trial management and vendor oversight. Of course MDCPartners’ ta-Scan team will be there too. The summit features 6 co-located conferences and 3 dinner short courses. Multiple registration options are available. Download the digital brochure for all details.

2017 Program Highlights

The 2017 Clinical Trial Innovation Summit program focuses on key issues and opportunities in the clinical trial industry, including patient recruitment, site selection, data integration, existing data sources, mobile tech, project management, outsourcing, vendor management, budgeting and contracting, quality (QbD) in trial conduct, risk-based monitoring and clinical auditing.

  • ICH E6 guidance, including gap analysis, action plans, and project plans from clinical trial quality and risk management expert Andy Lawton
  • An assessment of current and future trial technologies: social media, search engine optimization, targeted digital advertising, artificial intelligence and virtual reality
  • Real examples of big data analytics in clinical trials from Takeda, Bayer, Janssen, and BMS
  • Proven strategies for determining timelines, key activity needs, and effective communication for clinical trial outsourcing
  • Case studies from AbbVie, Merck, and Samumed on new methods of risk mitigation, issue management and oversight plans to ensure quality clinical trials
  • How to navigate regulation and data quality and quantity challenges of wearables, sensors and mHealth from pharma teams in the trenches
  • Lessons learned from AstraZeneca, BMS, Gilead, and several others at the frontline of RBM roll-out

Join us in Boston

Would you like to know how we can help with your company’s data challenges, using our clinical business intelligence software ta-Scan and our other data solutions? Then feel free to pop by at Booth #3 in the exhibition hall (Essex North / Center Ballroom) or make an appointment with MDCPartners Chief Scientific Officer David Cocker or Director of Business Development, North America Matt Tumasz. They will gladly show you our state of the art software tools.

Register Today

Use our discount code MDPCTL for $200 off your registration cost.*

How to Register:
Online: https://chidb.com/reg/ctl/reg.asp
By telephone: +1 781-972-5400

We hope to see you in Boston!

* Our clients and colleagues will receive $200 off for commercial attendees or $100 off for academic, government and hospital-affiliated attendees. You must mention priority keycode MDPCTL to receive the registration discount. Alumni, Twitter, LinkedIn, Facebook or any other promotional discounts cannot be combined. Discounts not applicable on event short courses. This discount does not apply to previously registered attendees.
MDCPartners ta-Scan 5 SCOPE 2017 Miami Florida

Events, News Published on October 28, 2016

Discover ta-Scan 5 at SCOPE 2017

Summit for Clinical Operations Executives

It’s never too early for good Year’s resolutions! Ours? Start off 2017 with a bang! Indeed, in January 2017, MDCPartners will travel to sunny Florida again for the yearly Summit for Clinical Operations Executives (SCOPE), and it goes without saying that we are already looking forward to it.

The 8th Annual SCOPE Summit, taking place January 24-26, 2017 in Miami, Florida in the Hyatt Regency, will offer three stimulating days of in-depth discussions in 13 different conferences, 6 pre-conference workshops and 2 symposia focused on issues related to each aspect of clinical trial planning and management: Data Integration, Feasibility, Site Selection and Management, Patient Engagement, Recruitment and Retention, Mobile Tech, Project Management, Outsourcing, Forecasting, Budgeting and Contracting, Quality (QbD) in Trial Conduct, Risk-Based Monitoring, Post-Marketing Studies, Observational Research, Clinical Lab Services, Precision Medicine and Biomarker-Driven Trials. View SCOPE’s programs here.

Introducing ta-Scan 5

ta-scan 5

Our business and IT teams will present the clinops experts at SCOPE ta-Scan‘s latest version we have been working on the last months: ta-Scan 5! This update includes a lot of new features and a complete style make-over to enhance the user experience. Join us in Miami to discover how our clinical business intelligence software and our public-private data integration skills can leverage today’s clinical big data challenges.

Meeting Up

ta-Scan team at SCOPE 2017 Miami Florida

If you want to get an exclusive preview of ta-Scan 5 and learn more about our software solutions, visit us at booth #702 or make an appointment with the team (from left to right, from top to bottom):

Bart Naudts, IT Partner
David Cocker, CSO
Mireille De Cré, CEO
Piet van Remortel, IT Partner
Matt Tumasz, Director of Business Development USA
Jonathan Crowther, Ph.D., Strategic Analyst Oncology
Alexandra Moens, Marketing Associate
Kristof Geentjens, Technical Product Manager

MDCPartners and ta-Scan at Big Data in Precision Medicine 2016 Washington, D.C.

Events Published on October 10, 2016

MDCPartners Innovation Partner Big Data in Precision Medicine Washington

Big Data in Precision Medicine

With ESMO 2016 coming to a close in Copenhagen, MDCPartners is getting ready for their next stop: we are this year’s Innovation Partner of the Big Data in Precision Medicine meeting, which will take place in the Capital Hilton in Washington, D.C. on November 1-2, 2016.

This meeting attracts 250-300 senior executives from across the drug development sector including Big Pharma, biotech, leading solution providers, government, healthcare and academia. The meeting addresses the opportunities and challenges of big and real-world data, and how machine learning and cognitive computing can be applied in the context of drug development. View the meeting’s streams and the meeting agenda here.

Private Clinical Trial Data in the Real-World Data Context

On Tuesday November 1 at 9:30 AM, MDCPartners’ Chief Scientific Officer David Cocker will present our findings on “The value case of private pharma clinical trial data in the real-world data context”.

Real-world data (RWD) is generally the term used to refer to any data which is collected outside of randomized clinical trials (RCT). The data can be from sources including patient data from hospitals and clinicians. The premise is that RWD combined with information from RCTs can provide better research outcomes and improved healthcare.

Unfortunately, available clinical trial information data is really not that big. Often it is also dispersed and contradictory, and includes duplicates through multiple entries that are not verified and/or matched. Many transformative actions with data are frequently heralded as a big data panacea long before any analytical conclusion can be applied.

This presentation will explore the challenges faced when approaching the question of clinical trial data merging and its interoperability with public clinical trial data for creating valuable insights for study placement.

Meeting Up

ta-Scan’s data team will be present in Washington, D.C. as well to show the precision medicine experts how our clinical business intelligence software ta-Scan can leverage today’s medical big data challenges.

If you want to learn more about our software solutions, you can meet us personally during the exhibition at booth #1 or make an appointment with CSO David Cocker, Director of Business Development, North America Matt Tumasz, or Strategic Data Analyst, Oncology Jonathan Crowther.

MDCPartners and ta-Scan at ESMO 2016 Copenhagen

Events Published on September 13, 2016

Meet the ta-Scan Oncology Team at ESMO 2016 in Copenhagen

European Society for Medical Oncology

Next stop on our bill: the ESMO 2016 Congress in Copenhagen, Denmark on 7-11 October 2016.

The annual ESMO congress is the premier scientific platform to present your oncology research and as such, the ultimate learning experience for congress attendees. Across disciplines and across cultures, ESMO bridges the gap between researchers, clinicians and patients and unites all stakeholders focused on finding the most effective cancer treatment solutions available today.

ESMO 2016 will continue to build upon the success of past congresses, offering a top-notch scientific and educational programme created by international experts in oncology. View the online meeting programme here.

Meeting up

ta-Scan’s oncology team will be present in Copenhagen as well to show the oncology society how our clinical business intelligence software ta-Scan can leverage today’s medical oncology data challenges.

If you want to learn more about our software solutions, you can meet us personally during the conference. Just make an appointment with David CockerJonathan Crowther, or Koen Snijders.

MDCPartners at Immunotherapy Leaders Berlin 2016

News Published on August 3, 2016

Meet the ta-Scan Team at Immunotherapy Leaders Europe

Immuno-oncology in Berlin

Enjoying the summer, we are also excited about what comes after: in September, the ta-Scan team will be present at Immunotherapy Leaders Europe, the annual meeting for Immuno-Oncologists in Berlin.

Biomarkers for patient selection

Learn how to use our clinical business intelligence portal ta-Scan to boost success rates in immuno-oncology clinical trials through biomarker-driven patient selection from Strategic Analyst Oncology Dr Jonathan Crowther‘s presentation on:

“Biomarker evolution and utility for patient selection in clinical research”

Wednesday, September 21,  2:45 – 3:05 PM
Stream 3: Boosting success rates in immuno-oncology clinical trials
through biomarker-driven patient selection

•  Using the clinical business intelligence platform ta-Scan to track the evolution of immunotherapy biomarkers and improve patient selection resulting in successful clinical research.
•  Analysis of the immuno-oncology biomarker landscape: What are the trending biomarkers and how do they compare across clinical research?
•  Improving on study design, the who and where in clinical research.
– Estimation of patient cohorts?
– Key opinion leaders in the field?
– What benchmarks have been previously established?
•   Geographical site selection
– Where are trials primarily taking place?
– What countries and locations are suitable for my trial?

Dr Jonathan Crowther

Jonathan Crowther is Strategic Analyst Oncology at MDCPartners where he is working on growing oncology-based projects on the ta-Scan platform. Jonathan holds a PhD from the VIB/University of Leuven (Belgium) where he studied the role of large scale deletions in cancer and explored their potential as novel biomarkers of drug response. Jonathan provided bioinformatic analysis and big data solutions to ongoing areas of research, working on large cancer patient data sets such as The Cancer Genome Atlas (TCGA). In this capacity Jonathan significantly contributed to a number of ongoing projects and has published on these topics.

Meeting up

You can also meet us personally at booth #27 to see a live demonstration of our ta-Scan software. Just drop by or make an appointment with David Cocker or Jonathan Crowther.

Oncology Leaders Forum 2016 Phacilitate

Events Published on April 4, 2016

Join ta-Scan at Oncology Leaders Forum 2016 in Boston

Are you visiting Boston’s Oncology Leaders Forum 2016 April 5-6? MDCPartners‘ ta-Scan team will be there exhibiting as well. Join us and attend chairman David Cocker’s presentation on “The Evolution Towards Precision: A Chronology of Transition” on April 5 at 2:35 PM:

• Standards of care. What’s changing in therapy focus?
• Scenario-based enrolment: forecasting and validation
• Footprint of global trial activity. Who is generating the data? KOL ranking.
• The death of the longitudinal drug development paradigm.
• Where will I be conducting my next trial?

Oncology Leaders Forum is the most senior oncology event in the pharmaceutical sector where 88% of the audience are Director-level and above for two days of strategic thinking and networking. Recognized as the leader by the leaders, the Oncology Leaders Forum is the event of choice for senior translational and clinical oncology R&D executives driving the development, registration and launch of novel cancer therapeutics of all classes, plus companion diagnostics. Click here to view the final meeting agenda.

 

Browse categories


Browse tags